ClinicalTrials.Veeva

Menu

Vitamins and Minerals for Children With Downs Syndrome

I

Institute of Child Health

Status

Completed

Conditions

Trisiomy 21 (Down Syndrome)

Treatments

Drug: Vitamins A,C,E Selenium and Zinc and Folinic acid.
Drug: Placebo
Drug: Folinic acid
Drug: Antioxidants- (Vitamins A,C,E Selenium and Zinc)

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The trial aimed to examine the effects of supplementation with antioxidants and folinic acid on the health, growth and psychomotor development of children with Down syndrome. 156 children with Trisomy 21, less than 7 months of age were recruited and randomised into four groups to receive antioxidants, folinic acid, a combination of antioxidants and folinic acid or a placebo. Blinded outcome assessment was carried out 18 months later.Blood and urine samples were also taken around 12 months of age to examine metabolic effects of supplementation.

Sex

All

Ages

Under 7 months old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Under 7 months of age
  • Trisomy 21
  • Live in recruitment Area-i.e. London inside M25, in West Midlands or SW England.
  • One parent speaks English

Exclusion criteria

  • No life threatening cardiac disease

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems